PURPOSE: This phase I trial is studying the side effects and best dose of sorafenib when given together with pemetrexed and cisplatin in treating patients with advanced solid tumors.
|
PURPOSE: This phase I trial is studying the side effects and best dose of sorafenib when given together with pemetrexed and cisplatin in treating patients with advanced solid tumors. |
||
|
Copyright © 2010 Mesothelioma information and other asbestos related injuries to patients, families and loved ones - All Rights Reserved |
||